Advertisement

Ads Placeholder
Loading...

OpGen, Inc.

OPGNNASDAQ
Healthcare
Medical - Diagnostics & Research
$23.91
$0.00(0.00%)
U.S. Market opens in 19h 53m

OpGen, Inc. (OPGN) Stock Overview

Explore OpGen, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap242.7M
P/E Ratio35.19
EPS (TTM)$0.18
ROE0.78%
Fundamental Analysis

AI Price Forecasts

1 Month$22.75
3 Months$40.76
1 Year Target$2.60

OPGN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of OpGen, Inc. (OPGN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.33, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.60.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 35.19 and a market capitalization of 242.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-3.98%
1-Month Change
-3.39%
3-Month Change
43.17%
6-Month Change
23909900.72%
Year-to-Date (YTD) Change
43.17%
1-Year Change
469.29%
3-Year Change
79.77%
5-Year Change
-95.73%
All-Time (Max) Change
-100.00%

Contact Information

240 813 1260
9717 Key West Avenue, Rockville, MD, 20850

Company Facts

850 Employees
IPO DateMay 5, 2015
CountryUS

Frequently Asked Questions